ARCHIVES

Tri-Institutional Stem Cell Initiative Funds Grants.

This article is from The Cancer Letter archive.

Vol. 32 No. 30 | August 4, 2006

Download PDF Visit The Full Archive

Related Articles

Diabetes Associated With Greater Risk Of Cancer

December 28, 2007

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

In Brief: Peter Vogt Names Bristol-Myers Winner; Other Awards: Koop, Weinberg, Wynder, Longmire

March 24, 1989

AACI Offers Ideas On How to Handel Cancer Control Problems, Issues

July 24, 1981

NCI-Approved Clinical Trials

June 24, 2005